Erik H.J.G. Aarntzen

Author

Also Known As

Aarntzen, Erik, Aarntzen, Erik H. J. G., E H J G Aarntzen, E. Aarntzen, E. H. J. G. Aarntzen, E.H.J.G. Aarntzen, Erik H. J. G. Aarntzen, Erik Aarntzen, Erik H Aarntzen, Erik H J G Aarntzen

272

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen Radboud Institute for Molecular Life Sciences University Medical Center Leiden University Medical Center

About

Erik H.J.G. Aarntzen is an author at Radboud University Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	705
2	Cell Biology	3	3	194
3	Health Sciences	2	2	44
4	Allergy	1	1	153
5	Hepatology	1	1	21

Erik H.J.G. Aarntzen

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients Jurjen Tel, Erik H.J.G. Aarntzen, Tetsuro Baba, Cancer Research ImmunologyPathologyCd4 T Cell ResponsesDermatologyImmunotherapy	2013	342
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Clinical Cancer Research	2015	231
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients Pauline Verdijk, Erik H.J.G. Aarntzen, W. Joost Lesterhuis, Clinical Cancer Research	2009	196
Improving the Diagnostic Performance of <sup>18</sup> F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis Laurens E. Swart, Anna Gomes, Asbjørn M. Scholtens, Circulation	2018	189
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Clinical Cancer Research	2011	187
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination Erik H.J.G. Aarntzen, I. Jolanda M. de Vries, W. Joost Lesterhuis, Cancer Research Adaptive Immune SystemImmunodeficienciesImmunologyImmunoeditingImmunodominance	2012	153
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration A.C.I. Boullart, Erik H.J.G. Aarntzen, Pauline Verdijk, Cancer Immunology Immunotherapy	2008	150
A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis Carolijn Smids, Ilse J.E. Kouijzer, Fidel J. Vos, Infection	2016	126
Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis Benjamin Weide, Henning Zelba, Evelyna Derhovanessian, Journal of Clinical Oncology	2012	116
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort, Journal for ImmunoTherapy of Cancer	2019	110

Page 1